Literature DB >> 8021706

Rachelle Fishman-Matthew Moore Lecture. The pathological and clinical dynamics of multiple sclerosis.

W I McDonald1.   

Abstract

The application of magnetic resonance imaging, spectroscopy and electrophysiological techniques to the study of multiple sclerosis has enhanced our understanding of the mechanism of relapse and remission. The earliest detectable event in the development of a new lesion is an increase in permeability of the blood-brain barrier associated with inflammation. Demyelination occurs early in the inflammatory phase. Both processes contribute to conduction block and functional loss. When the inflammation subsides, edema resolves and conduction is restored probably as a result of the expansion of sodium channels into the demyelinated axon. Remyelination is not essential to remission. Wallerian degeneration may be an important factor contributing to irrecoverable deficit.

Entities:  

Mesh:

Year:  1994        PMID: 8021706     DOI: 10.1097/00005072-199407000-00003

Source DB:  PubMed          Journal:  J Neuropathol Exp Neurol        ISSN: 0022-3069            Impact factor:   3.685


  13 in total

1.  Visualization of nonstructural changes in early white matter development on diffusion-weighted MR images: evidence supporting premyelination anisotropy.

Authors:  D Prayer; A J Barkovich; D A Kirschner; L M Prayer; T P Roberts; J Kucharczyk; M E Moseley
Journal:  AJNR Am J Neuroradiol       Date:  2001-09       Impact factor: 3.825

2.  Differentiation and quantification of inflammation, demyelination and axon injury or loss in multiple sclerosis.

Authors:  Yong Wang; Peng Sun; Qing Wang; Kathryn Trinkaus; Robert E Schmidt; Robert T Naismith; Anne H Cross; Sheng-Kwei Song
Journal:  Brain       Date:  2015-02-26       Impact factor: 13.501

Review 3.  Magnetic resonance spectroscopy in vivo: applications in neurological disorders.

Authors:  D L Arnold; N De Stefano
Journal:  Ital J Neurol Sci       Date:  1997-12

4.  1H-MRS in patients with multiple sclerosis undergoing treatment with interferon beta-1a: results of a preliminary study.

Authors:  P Sarchielli; O Presciutti; R Tarducci; G Gobbi; A Alberti; G P Pelliccioli; A Orlacchio; V Gallai
Journal:  J Neurol Neurosurg Psychiatry       Date:  1998-02       Impact factor: 10.154

5.  Conduction in segmentally demyelinated mammalian central axons.

Authors:  P A Felts; T A Baker; K J Smith
Journal:  J Neurosci       Date:  1997-10-01       Impact factor: 6.167

6.  Polyreactive myelin oligodendrocyte glycoprotein antibodies: Implications for systemic autoimmunity in progressive experimental autoimmune encephalomyelitis.

Authors:  Lisa K Peterson; Ikuo Tsunoda; Takahisa Masaki; Robert S Fujinami
Journal:  J Neuroimmunol       Date:  2007-01-02       Impact factor: 3.478

7.  Occludin as direct target for glucocorticoid-induced improvement of blood-brain barrier properties in a murine in vitro system.

Authors:  Carola Förster; Christine Silwedel; Nikola Golenhofen; Malgorzata Burek; Silke Kietz; Joachim Mankertz; Detlev Drenckhahn
Journal:  J Physiol       Date:  2005-03-24       Impact factor: 5.182

Review 8.  Brain and spinal cord atrophy in multiple sclerosis: role as a surrogate measure of disease progression.

Authors:  J H Simon
Journal:  CNS Drugs       Date:  2001       Impact factor: 5.749

Review 9.  Proton magnetic resonance spectroscopy in brain white matter disorders.

Authors:  N De Stefano; A Federico; D L Arnold
Journal:  Ital J Neurol Sci       Date:  1997-12

10.  Glucocorticoid effects on mouse microvascular endothelial barrier permeability are brain specific.

Authors:  Carola Förster; Jens Waschke; Malgorzata Burek; Jörg Leers; Detlev Drenckhahn
Journal:  J Physiol       Date:  2006-03-16       Impact factor: 5.182

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.